GRPS · Trans American Aquaculture, Inc
$0.00
At close · Aug 11
Going-concern doubt
— flagged Jan 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These factors, as relative to capital raising activities, create doubt as to our ability to continue as a going concern.”View the 10-Q filed Jan 14, 2026
Market Cap
$180,592
Shares
1.81B
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$0.00
Open$0.00
Day$0.00–0.00
52W close$0.00–0.00
Avg vol 30d1.5M
Short int115 · 0.0% float · 1.0d
Short vol100%
DataJan 2020–Aug 2026
Filing10-Q · Jan 14
Up next
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed Jan 14, 2026
Equibles Rating
blended score · not investment adviceOverall
Sell
SellHoldBuy
Technical
Sell
Momentum
Very Weak
Sentiment
Neutral
Fundamentals
Fair
Quant / Vol
High
Market backdrop
VIX 14.4 · calm
Equity put/call 0.62
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
−50%
below
Price vs 50-day avg
−67%
below
RSI (14)
27
oversold
MACD trend
Positive
52-week position
0%
near low
Momentum
relative strength
1-month return
−67%
trailing
6-month return
−80%
trailing
YTD return
−67%
this year
Relative strength
−92%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $0 › 200d $0 — 50d above 200d
Institutional flow
Flat
No 13F holder data
Insider flow
Flat
No net insider activity over 90 days
Short interest
Flat
0.00% of float · ▬ 0.0% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
No 13F holder history
Squeeze score
12
low risk · 0–100
Fundamentals
Revenue growth
+227%
Y/Y
Gross margin
3%
expanding
EPS growth
−22%
Y/Y
Balance sheet
$54.5K
net debt
Quant / Vol
risk profile
Volatility
485%
annualized · 1-yr
Max drawdown
−80%
past year
ATR
0.0%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Sell
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
−50%
Bearish
Price vs 50-day avg
−67%
Bearish
RSI (14)
27
Neutral
MACD trend
Positive
Bullish
52-week position
0%
Bearish
Market signals — smart money & positioning
No clear signal
Trend (MA cross)
No cross
50d $0 › 200d $0 — 50d above 200d
Institutional flow
Flat
No 13F holder data
Insider flow
Flat
No net insider activity over 90 days
Short interest
Flat
0.00% of float · ▬ 0.0% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
No 13F holder history
Price context
position in its 52-week range
Range low $0
Now $0 · 0%
Range high $0
vs 200-day avg -50%
vs 50-day avg -67%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Drug Manufacturers - Specialty & Generic — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
GRPS
this stock
Trans American Aquaculture, Inc
|
$180,592 | -66.7% | +226.5% | — | 0.0% |
|
JHPCY
Jiangsu Hengrui Pharmaceuticals Co., Ltd./ADR
|
$66.37B | — | — | — | 0.0% |
|
TAK
Takeda Pharmaceutical Co Ltd
|
$57.58B | +15.7% | — | — | 0.1% |
|
GALDY
Galderma Group AG/ADR
|
$49.38B | +2.2% | — | — | 0.0% |
|
HLN
Haleon plc
|
$44.46B | +0.0% | — | — | 0.3% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionShort & Settlement
Financials
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| GRPS | -50.0% | -66.7% | -80.0% | -50.0% | -66.7% |
| SPY | -0.1% | +2.5% | +12.3% | +3.2% | +13.0% |
| vs SPY | -49.9% | -69.2% | -92.3% | -53.2% | -79.7% |
Key facts
CIK
1990446